Onkológia 6/2016
Skin toxicity of EGFR inhibitors
Targeted therapies with epidermal growth factor inhibitors offer more precise treatment options for oncological patient,however,they are not free of adverse effects. Cutaneous adverse effects are among the most frequently encountered and signifiantly impact both , quality of life and health care economics. Dermatovenerologists can provide key input in the management of skin toxicities in patients with targeted cancer therapies.
Keywords: targeted therapy with EGFRI, skin toxicities, management
